In light of the risks and harms cosmetic treatment can cause in patients with body dysmorphic disorder, having a systematic process for identifying such patients is imperative. Researchers recently published their results from using a screening questionnaire for this purpose.
The researchers utilized the Body Dysmorphic Disorder Questionnaire (BBDQ) and the Body Dysmorphic Disorder Structured Clinical Interview for DSM-IV (BBD SCID) in 234 patients who presented to a busy academic facial plastic and reconstructive surgery clinic to determine the prevalence of body dysmorphic disorder (BDD). Additionally, the BDD SCID and a defect severity scale were used to confirm BDD diagnosis and validate BDDQ findings, and demographic characteristics, depression and anxiety were measured in all patients.
Lisa E. Ishii
The BDD SCID confirmed BDD in 13.1% patients undergoing cosmetic surgery and in 1.8% of those undergoing reconstruction surgery. The BDDQ was determined to be 91.7% accurate, 100% sensitive and 90.3% accurate in screening patients for BDD, according to the researchers.
In patients with BDD, the nose was determined to be of most concern (56%), followed by the skin (28%), hair (6%), chin (6%) and ears (6%).
Patients with BDD were found to have elevated depression levels compared with patients without BDD.
In the non-BDD population, mean state and trait anxiety scores resembled the norm for both men and women, according to the researchers. – by Abigail Sutton
Disclosures: The authors report no relevant financial disclosures.